LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...

Scientists have developed a DNA nanoflower that delivers chemotherapy and gene therapy directly to breast cancer cells, ...

Discover how high-content analysis enhances live-cell imaging by enabling detailed, quantitative insights into cellular behavior over time.

New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...

This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...

In this webinar, Kevin Grady and Manisha Nautiyal will outline how to make predictive 3D cell models for therapeutic ...

Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at advanced stages, ...

Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body—not only during normal tissue ...

Researchers at UBC Okanagan have made two major discoveries that are set to revolutionize how scientists observe and measure ...

New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer ...